Search





Search





Markets
/
Stocks
/
olma
/

Olema Pharmaceuticals Inc

OLMA

Add to Watchlist

11.450USD

-0.370-3.13%

Close 07-31 16:00（ET）Quotes delayed by 15 min

1.00BMarket Cap

LossP/E TTM

Olema Pharmaceuticals Inc

11.450

-0.370-3.13%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

OLMA Cash Flow Statement

You can access the annual and quarterly cash flow statements of Olema Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q2

FY2020Q1

FY2019Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-4.57%-45.99M

-45.82%-38.33M

-27.80%-34.53M

-8.45%-29.88M

-87.18%-43.98M

-42.26%-26.28M

-18.78%-27.02M

-24.59%-27.55M

-15.23%-23.50M

6.27%-18.48M

-26.41%-22.74M

16.41%-22.12M

-13.90%-20.39M

-5.96%-19.71M

-48.72%-17.99M

-197.13%-26.46M

-61.52%-17.90M

-106.40%-18.60M

---12.10M

-654.02%-8.90M

-418.91%-11.08M

-962.85%-9.01M

---1.18M

---2.14M

---848.00K

Net income from continuing operations

-74.70%-53.09M

-37.22%-46.06M

-22.17%-42.22M

-44.11%-43.78M

1.88%-30.39M

-25.38%-33.57M

-60.71%-34.55M

-51.19%-30.38M

-9.49%-30.97M

-2.27%-26.77M

5.36%-21.50M

38.84%-20.09M

-22.82%-28.29M

-20.99%-26.18M

-28.27%-22.72M

-100.28%-32.86M

-50.14%-23.03M

-113.58%-21.64M

---17.71M

-568.81%-16.41M

-806.02%-15.34M

-896.17%-10.13M

---2.45M

---1.69M

---1.02M

Operating gains losses

-7.03%119.00K

61.21%187.00K

-54.74%43.00K

40.43%132.00K

45.45%128.00K

31.82%116.00K

5.56%95.00K

-5.05%94.00K

-12.00%88.00K

-9.28%88.00K

-1.10%90.00K

16.47%99.00K

19.05%100.00K

32.88%97.00K

82.00%91.00K

174.19%85.00K

833.33%84.00K

1725.00%73.00K

--50.00K

1450.00%31.00K

200.00%9.00K

33.33%4.00K

--2.00K

--3.00K

Other non-cash items

46.42%-972.00K

36.17%-856.00K

40.40%-1.02M

25.16%-1.43M

12.24%-1.81M

31.12%-1.34M

-78.25%-1.71M

-145.05%-1.90M

-281.37%-2.07M

-694.69%-1.95M

-801.46%-961.00K

-365.19%-777.00K

-264.74%-542.00K

-119.14%-245.00K

67.07%137.00K

295.95%293.00K

414.06%329.00K

--1.28M

--82.00K

--74.00K

--64.00K

----

--0.00

Change in working capital

86.53%-2.19M

90.12%4.14M

25.12%4.42M

1066.15%10.50M

-458.32%-16.28M

-62.51%2.18M

177.11%3.53M

80.31%-1.09M

22.58%4.54M

230.71%5.80M

-2135.11%-4.58M

-526.99%-5.52M

1576.89%3.71M

159.59%1.75M

-83.03%225.00K

-62.79%1.29M

-125.77%-251.00K

-134.10%-2.94M

--1.33M

211.38%3.48M

189.60%974.00K

-857.83%-1.26M

--1.12M

---1.09M

--166.00K

-Change in prepaid expenses

373.04%2.60M

-134.14%-4.46M

334.46%347.00K

-6286.67%-1.86M

-65.54%549.00K

-574.81%-1.90M

-23.33%-148.00K

104.82%30.00K

53.91%1.59M

119.85%401.00K

16.08%-120.00K

-2043.75%-622.00K

501.74%1.03M

-58.81%-2.02M

-140.40%-143.00K

-94.55%32.00K

-40.89%172.00K

43.01%-1.27M

--354.00K

186.34%587.00K

174.62%291.00K

-5290.70%-2.23M

--205.00K

---390.00K

--43.00K

-Change in other current assets

89.64%-100.00K

-34.78%-496.00K

-2241.92%-3.91M

28.36%-773.00K

28.15%-965.00K

-9300.00%-368.00K

96.79%-167.00K

-711.28%-1.08M

---1.34M

--4.00K

-808.22%-5.20M

55.96%-133.00K

100.00%0.00

---572.00K

---302.00K

---240.00K

94.08%-30.00K

----

---507.00K

----

-Change in other current liabilities

111.59%1.30M

62.83%3.63M

1.43%5.90M

257.01%12.70M

-2684.16%-11.25M

-56.87%2.23M

1140.72%5.82M

166.08%3.56M

-115.01%-404.00K

38.37%5.17M

-65.67%469.00K

-365.43%-5.38M

2481.42%2.69M

848.90%3.74M

16.06%1.37M

-29.66%2.03M

-111.19%-113.00K

-117.98%-499.00K

--1.18M

2872.16%2.88M

3507.14%1.01M

--2.77M

--97.00K

--28.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-4.57%-45.99M

-45.82%-38.33M

-27.80%-34.53M

-8.45%-29.88M

-87.18%-43.98M

-42.26%-26.28M

-18.78%-27.02M

-24.59%-27.55M

-15.23%-23.50M

6.27%-18.48M

-26.41%-22.74M

16.41%-22.12M

-13.90%-20.39M

-5.96%-19.71M

-48.72%-17.99M

-197.13%-26.46M

-61.52%-17.90M

-106.40%-18.60M

---12.10M

-654.02%-8.90M

-418.91%-11.08M

-962.85%-9.01M

---1.18M

---2.14M

---848.00K

Investing cash flow

Net cash from continuing investing activities

----

--0.00

-100.00%0.00

----

--0.00

100.00%0.00

--6.00K

--153.00K

-100.00%0.00

-110.07%-14.00K

-100.00%0.00

-75.25%173.00K

44.79%139.00K

-94.17%21.00K

-92.86%30.00K

1270.59%699.00K

--96.00K

5900.00%360.00K

4566.67%420.00K

--51.00K

--6.00K

--9.00K

--0.00

Capital expenditures

----

--0.00

-100.00%0.00

----

--0.00

--6.00K

--153.00K

-100.00%0.00

-75.25%173.00K

44.79%139.00K

-94.17%21.00K

-92.86%30.00K

1270.59%699.00K

--96.00K

5900.00%360.00K

4566.67%420.00K

--51.00K

--6.00K

--9.00K

--0.00

Net cash flow from disposal of fixed assets

----

--0.00

-100.00%0.00

----

--0.00

100.00%0.00

--6.00K

--153.00K

-100.00%0.00

-110.07%-14.00K

-100.00%0.00

-75.25%173.00K

44.79%139.00K

-94.17%21.00K

-92.86%30.00K

1270.59%699.00K

--96.00K

5900.00%360.00K

4566.67%420.00K

--51.00K

--6.00K

--9.00K

--0.00

Net cash flow from investment products

110.05%4.53M

-41.74%-162.18M

-62.38%17.27M

802.67%34.23M

-125.52%-45.08M

-270.12%-114.42M

280.43%45.92M

-134.52%-4.87M

-153.47%-19.99M

-287.26%-30.91M

-225.35%-25.45M

-52.05%14.11M

46.06%37.39M

146.44%16.51M

260.02%20.30M

160.70%29.43M

109.17%25.60M

--6.70M

---12.69M

--11.29M

---279.16M

----

--0.00

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

110.05%4.53M

-41.74%-162.18M

-62.38%17.27M

801.80%34.23M

-123.80%-45.08M

-270.12%-114.42M

280.53%45.92M

-134.56%-4.88M

-153.88%-20.14M

-289.24%-30.91M

-226.15%-25.44M

-52.02%14.11M

46.23%37.39M

172.27%16.34M

257.73%20.16M

169.09%29.41M

109.14%25.57M

11864.71%6.00M

---12.78M

182266.67%10.93M

-3106388.89%-279.58M

---51.00K

---6.00K

---9.00K

--0.00

Financing cash flow

Cash flow from continuous financing activities

20487.39%45.70M

-12.59%213.55M

-55.43%41.00K

-116.14%-2.52M

-97.48%222.00K

46611.28%244.30M

-99.93%92.00K

663.83%15.61M

3909.55%8.82M

91.58%523.00K

123134.91%130.63M

3092.19%2.04M

566.67%220.00K

-66.63%273.00K

85.96%106.00K

-87.60%64.00K

--33.00K

-99.63%818.00K

--57.00K

-97.83%516.00K

----

--219.79M

--23.75M

--29.99M

--0.00

Net cash flow from debt Issuance/repayment

----

--0.00

--3.00M

----

--0.00

----

--0.00

--3.00M

--0.00

Net cash flow from common stock issuance/repurchase

--41.92M

98307.66%205.67M

--0.00

-95.19%748.00K

----

-38.35%209.00K

--0.00

2085.09%15.54M

--7.90M

24.18%339.00K

--0.00

1147.37%711.00K

----

-18.51%273.00K

--0.00

-85.23%57.00K

----

-99.85%335.00K

--0.00

--386.00K

----

--220.55M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

--0.00

--23.75M

--26.99M

--0.00

Proceeds from stock option exercised by employees

3472.03%8.43M

1235.59%7.88M

-55.43%41.00K

239.13%234.00K

-74.35%236.00K

183.65%590.00K

-89.41%92.00K

-94.82%69.00K

318.18%920.00K

--208.00K

719.81%869.00K

18928.57%1.33M

566.67%220.00K

-100.00%0.00

85.96%106.00K

-94.62%7.00K

--33.00K

48200.00%483.00K

--57.00K

--130.00K

----

--1.00K

----

--0.00

Net cash flow from other financing activities

-33071.43%-4.64M

-100.00%0.00

--0.00

---6.50M

---14.00K

1014687.50%243.50M

----

---24.00K

--129.76M

----

--0.00

----

---762.00K

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

20487.39%45.70M

-12.59%213.55M

-55.43%41.00K

-116.14%-2.52M

-97.48%222.00K

46611.28%244.30M

-99.93%92.00K

663.83%15.61M

3909.55%8.82M

91.58%523.00K

123134.91%130.63M

3092.19%2.04M

566.67%220.00K

-66.63%273.00K

85.96%106.00K

-87.60%64.00K

--33.00K

-99.63%818.00K

--57.00K

-97.83%516.00K

----

--219.79M

--23.75M

--29.99M

--0.00

Net cash flow

Beginning cash balance

-65.37%48.30M

-1.75%35.26M

210.64%52.47M

-100.00%0.00

103.50%139.48M

-69.43%35.89M

-51.68%16.89M

-17.59%33.72M

189.17%68.54M

338.02%117.41M

42.53%34.96M

90.24%40.92M

71.60%23.70M

4.72%26.80M

-51.36%24.53M

-55.08%21.51M

-95.92%13.81M

-79.97%25.60M

--50.42M

71.56%47.88M

497766.18%338.55M

13854.59%127.82M

--27.91M

--68.00K

--916.00K

Current period cash flow changes

104.78%4.25M

-87.41%13.04M

-190.61%-17.21M

110.89%1.83M

-155.15%-88.84M

311.98%103.59M

-76.96%19.00M

-182.35%-16.83M

-302.25%-34.82M

-1475.37%-48.87M

3519.36%82.45M

-297.55%-5.96M

123.67%17.22M

73.68%-3.10M

109.18%2.28M

18.73%3.02M

102.65%7.70M

-105.59%-11.79M

---24.82M

-88.74%2.54M

-1144.03%-290.67M

24949.65%210.72M

--22.57M

--27.84M

---848.00K

Ending cash balance

3.77%52.55M

-65.37%48.30M

-1.75%35.26M

-89.15%1.83M

50.18%50.64M

103.50%139.48M

-69.43%35.89M

-51.68%16.89M

-17.59%33.72M

189.17%68.54M

338.02%117.41M

42.53%34.96M

90.24%40.92M

71.60%23.70M

4.72%26.80M

-51.36%24.53M

-55.08%21.51M

-95.92%13.81M

--25.60M

-0.11%50.42M

71.56%47.88M

497766.18%338.55M

--50.48M

--27.91M

--68.00K

Free cash flow

-4.57%-45.99M

-45.82%-38.33M

-27.80%-34.53M

-8.42%-29.88M

-85.97%-43.98M

-42.26%-26.28M

-18.78%-27.02M

-24.62%-27.56M

-15.98%-23.65M

7.08%-18.48M

-25.44%-22.74M

16.48%-22.12M

-13.71%-20.39M

-3.02%-19.88M

-48.69%-18.13M

-185.81%-26.48M

-55.88%-17.93M

-112.95%-19.30M

---12.19M

-680.54%-9.27M

-436.32%-11.50M

-968.87%-9.06M

---1.19M

---2.15M

---848.00K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Olema Pharmaceuticals Inc Generate?



Olema Pharmaceuticals Inc generated -146.72M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Olema Pharmaceuticals Inc's Operating Cash Flow Change Year Over Year?



Olema Pharmaceuticals Inc's operating cash flow increased by -40.60% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Olema Pharmaceuticals Inc's Financing Cash Flow Changed?



Olema Pharmaceuticals Inc used 211.30M in financing activities in the latest quarter.

What is free cash flow and why does it matter for OLMA?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Olema Pharmaceuticals Inc’s free cash flow in the latest quarter?



Free cash flow was -146.72M reflecting a -40.38% change from the previous year.